|
|
|
| 08h15 - 09h00 | - SESSION 1: FEMALE CANCERS, GLOBAL AND MULTIDISCIPLINARY ASPECTS
Chairs : M. ESPIE (Paris, France), C.MATHELIN (Strasbourg, France), F. LECURU (Paris, France)
| | | Female cancers in France and Europe - C. MATHELIN (Strasbourg, France) |
| | | What is the future for medication in oncology? - M. MARTY (Paris, France) |
| | | Management of targeted therapy in female cancers (breast excluded) - P. COMBE (Paris, France) - (See Video) -  |
| |
| 09h00 - 09h45 | - SESSION 2: SPORT AND GYNECOLOGY CANCERS
Head of the session: C. CUVIER (Paris, France)
| | | Sport and prevention of gynecological cancers, action’ mechanisms - C. MAITRE (Paris, France) - (See Video) - |
| | | Sport, fatique and quality of life and breast cancer treatment - C. CUVIER (Paris, France) - (See Video) - |
| | | Physical activity and upper limb after surgery for breast cancer - S. VIGNES (Paris, France) - (See Video) |
| |
| 09h45 - 10h30 | - SESSION 3: UPDATE ON MEDICAL TREATMENTS OF BREAST CANCERS
Heads of the session: M. ESPIE (Paris, France), M. BAHADOOR(Clermont-Ferrand, France)
| | | Anti-HER2 treatments - M. ESPIE (Paris, France) |
| | | M-TOR inhibitors and hormonotherapy - L. TEIXEIRA (Paris, France) |
| | | Update on neo-adjuvant treatments - S. GIACCHETTI (Paris, France) |
| |
| 11h00 - 11h45 | - SESSION 4: RADIOTHERAPY AND FEMALE CANCERS - Radiotherapy of lymph nodes areas
Chairs: Y. BELKACEMI (Paris, France), C. HENNEQUIN (Paris, France), JM. BIBAULT (Lille, France)
| | | Radiotherapy of lymph nodes areas
In favor: V. PERNIN, Y. KIROVA (Paris, France) - Against: C. HENNEQUIN (Paris, France) |
| | | Cardiac toxicity and lymph nodes irradiation: how to decrease it? - N. GRELLIER, Y. BELKACEMI (Paris, France) - (See Video) - |
| |
| 11h45 - 12h30 | - SESSION 5: NUCLEAR MEDICINE AND FEMALE CANCERS
Head of the session: D. GROHEUX (Paris, France) - Moderators: D. LE GULUDEC (Paris, France), JP. VUILLEZ (Grenoble, Paris)
| | | Role of 18F-FDG PET/CT in the initial staging of breast cancer - D. GROHEUX (Paris, France) - (See Video) - |
| | | Role of PET/CT in the early assessment of response to neoadjuvant chemotherapy for breast cancer - A. COCHET (Dijon, France) - (See Video) - |
| | | Role of 18F-FDG PET/CT in patients with metastatic breast cancer - JL. ALBERINI (Paris, France) - (See Video) - |
| |
| 12h30 - 13h30 | | | | 3D automated breast ultrasound combined with digital mammography: the proven multimodality approach to examine women with dense breast tissue - L. TABAR (Stockholm, Sweden) - (See Video) - |
| |
| 13h30 - 13h45 | | | | Prospective evaluation of trastuzumab administered concurrently with locoregional breast radiotherapy - J. JACOB (Paris, France) - (See Video) - |
| |
| 13h45 - 14h30 | - SESSION 6: TREATMENT OF OVARIAN CANCERS
Head of the session: E. PUJADE-LAURAINE (Paris, France) - Under the Auspices of the french group GINECO and the “Centre Cancer de la Femme et Recherche Clinique” (Paris Descartes, APHP) - Moderator: I. Ray-Coquard (Lyon, France)
| | | It is necessary to do more neoadjuvant chemotherapy? - F. LECURU (Paris, France) - |
| | | How manage in France the rare ovarian tumors, which are however common. - I. RAY-COQUARD (Lyon, France) |
| | | Advances in biologic therapies: anti-angiogenic, anti-PARP, folate antireceptor? - L. GLADIEFF (Toulouse, France) |
| | | Conclusion - I. RAY-COQUARD (Lyon, France) |
| |
| 14h30 - 15h15 | - SESSION 7: TREATMENT OF UTERINE CANCERS
Head of the session: F. LECURU (Paris, France)
| | | Pelvectomy: what are the results in 2014 - P. MATHEVET (Lausanne, Schwitzerland) |
| | | Sentinel node in uterine cancer: towards a new standard? - P. MATHEVET (Lausanne, Schwitzerland) - (See Video) - |
| | | Fertility preservation in uterine cancers - E. ADDA-HERZOG (Paris, France) - (See Video) - |
| |
| 15h45 - 16h15 | | | | The blockage of the interaction PD1/PDL1 in metastatic melanoma - C. LEBBE (Paris, France) |
| |
| 16h15 - 17h00 | - SESSION 8: FERTILITY AND CANCERS
Heads of the session: M. GRYNBERG (Paris, France), R. FRYDMAN (Suresnes, France)(France)
| | | Fertility in women treated for cancer in childhood - H. EL HACHEM (Paris, France) |
| | | Fertility and radiotherapy - S. RIVERA (Paris, France) |
| | | Fertility and ovarian tumors - V. FOURCHOTTE (Paris, France) |
| |
|
|
| |
|
|
|
